Sign in
4

Changes in Ownership

ImmunityBio, Inc. Filed Acc 0001326110-25-000003

Chief Financial Officer gave up 15,405 shares (to pay taxes)

  • Chief Financial Officer acquired 30,397 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Sachs David C. Chief Financial Officer 2024-12-31 Option exercise +30,397 216,235 D: show line 1 in the form
Sachs David C. Chief Financial Officer 2024-12-31 Shares withheld for taxes −15,405 $2.56 $39,437 200,830 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Sachs David C. Chief Financial Officer 2024-12-31 Option exercise · Restricted Stock Units −30,397 75,999 D: show line 3 in the form
Loading xslF345X05/wk-form4_1735941259.xml…